ID   H16N-2
AC   CVCL_IP82
SY   H16N2
DR   Cell_Model_Passport; SIDM01809
DR   Wikidata; Q54871957
RX   DOI=10.1007/978-1-4612-0411-4_18;
CC   Transfected with: UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Transfected with: UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008359.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 10
//
RX   DOI=10.1007/978-1-4612-0411-4_18;
RA   Band V., Sager R.;
RT   "Tumor progression in breast cancer.";
RL   (In) Neoplastic transformation in human cell system. Mechanism of carcinogenesis; Rhim J.S., Dritschilo A. (eds.); pp.169-178; Humana Press; New York (1990).
//